Delivery Order SPE2DB20D3103-SPE2DB24FM8L2

Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $16K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,443.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of January 18, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies. The contract, valued at $1,113.99, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award, valued at $12,938.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565110719 ! LIDOCAINE 5% PATCH 30S, a pharmaceutical product, and has an ultimate completion date of July 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating...
This federal contract award, valued at $1,959.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567027754 - LIDOCAINE 5% PATCH 30S, a medical supply item. The contract is a Firm Fixed Price Delivery Order with a completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, valued at $1,525.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567615853 - LIDOCAINE 5% PATCH 30S, a medical product, with a period of performance through March 19, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing mechanism. This award does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,181.92 firm fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to support the DLA Troop Support Medical program. The award is part of a larger Indefinite Delivery Contract (IDC) with Cencora, Inc. valued up to $999,999,999.00, which provides a comprehensive range of pharmaceutical...
This federal contract award, valued at $1,006.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566914877 - LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of January 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with any set-aside designation, indicating open competition....
This federal contract award, valued at $1,623.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4568207941 LIDOCAINE 5% PATCH 30S, a medical product, with a performance period extending through May 12, 2025. The contract is designated as a Firm Fixed Price Delivery Order, with no set-aside requirements. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D2005|SPE2DB25FJLX4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568141700 - LIDOCAINE 5% PATCH 30S, with a ceiling value of $1,360.47. It is a Firm Fixed Price Delivery Order contract, with a period of performance through May 6, 2025. This award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award, valued at $8,531.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LIDOCAINE 5% PATCH 30S medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM8L2
    Delivery Order

This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM8L2, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563797832 LIDOCAINE 5% PATCH 30S, a pharmaceutical product, with a ceiling value of $15,865.67 and a period of performance through February 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was awarded on February 28, 2024. The place of performance is Conshohocken, PA. This award is not associated with a set-aside program, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs, including the military and veteran populations.

Generated 5/14/25, 10:21 AM